Singapore markets close in 1 hour 24 minutes

Ono Pharmaceutical Co., Ltd. (OPHLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
21.560.00 (0.00%)
At close: 09:30AM EST
Show:
Annual

Income statement

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
31/03/2020
31/03/2019
Total revenue
403,985,000
361,361,000
309,284,000
292,420,000
288,634,000
Cost of revenue
101,656,000
93,511,000
85,573,000
79,063,000
83,829,000
Gross profit
302,330,000
267,850,000
223,711,000
213,356,000
204,805,000
Operating expenses
Research development
82,955,000
75,879,000
62,384,000
66,497,000
70,008,000
Selling general and administrative
82,346,000
77,057,000
69,230,000
67,679,000
70,033,000
Total operating expenses
177,033,000
164,654,000
125,381,000
135,866,000
142,795,000
Operating income or loss
125,297,000
103,196,000
98,330,000
77,490,000
62,010,000
Interest expense
991,000
874,000
137,000
845,000
150,000
Income before tax
126,813,000
105,025,000
100,890,000
79,696,000
65,141,000
Income tax expense
30,020,000
24,340,000
25,392,000
19,808,000
13,462,000
Income from continuing operations
96,793,000
80,685,000
75,498,000
59,888,000
51,679,000
Net income
96,568,000
80,519,000
75,425,000
59,704,000
51,539,000
Net income available to common shareholders
96,568,000
80,519,000
75,425,000
59,704,000
51,539,000
Basic EPS
-
162.19
151.11
118.47
100.25
Diluted EPS
-
162.16
151.09
118.45
100.24
Basic average shares
-
496,459
499,137
503,975
514,121
Diluted average shares
-
496,527
499,203
504,044
514,171
EBITDA
-
123,620,000
116,847,000
94,755,000
75,912,000